It has been demonstrated that the risk encompasses several POP weeks and the prophylaxis should be extended, primarily in patients at special risks 4,5,11,12.
Se ha demostrado que el riesgo abarca varias semanas POP y la profilaxis debe ser extendida, principalmente en pacientes con riesgos especiales 4,5,11,12.